Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Regeneron

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Regeneron's Japan sales performance.

regeneron

Regeneron reveals first data for bispecific antibody in multiple myeloma

Regeneron reveals first data for bispecific antibody in multiple myeloma Regeneron has made its first appearance on the BCMA scene, revealing data for its bispecific antibody candidate REGN5458 in multiple myeloma. . ... At the beginning of the year, Sanofi updated its $2.17bn immuno-oncology deal with Regeneron, paying

Sanofi’s new CEO cuts first deal, adding Synthorx for $2.5bn

Sanofi’s new CEO cuts first deal, adding Synthorx for $2.5bn squamous cell carcinoma (CSCC). The Regeneron-partnered drug is the first drug in the checkpoint inhibitor class to get a green light in that type of skin cancer, and is also ... Sanofi and Regeneron are also working on  bispecific antibody

J&J and Bristol-Myers Squibb/Bluebird bio reveal rival CAR-T data

J&J and Bristol-Myers Squibb/Bluebird bio reveal rival CAR-T data Both could face bispecific antibody competition, however, from the likes of Regeneron among others. ... Regeneron also  presented data for its candidate in multiple myeloma at ASH, which demonstrated a 75% response rate in the higher dosed group.

Novartis strengthens case for its combination asthma drug

Novartis strengthens case for its combination asthma drug However, GSK is not the only pharm company vying for space in the asthma market – Sanofi/Regeneron’s  Dupixent(dupilumab) is also establishing a presence in the therapy area, as well

Novartis acquires The Medicines Company for $9.7bn following takeover rumours

Novartis acquires The Medicines Company for $9.7bn following takeover rumours MedCo’s drug could pose a major challenge to established drugs in the class, including Amgen’s Repatha (evolocumab) and Sanofi/Regeneron’s Praluent (alirocumab).

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics